Avoid them
Therefore, if the newborn screening detects low carnitine levels, both the baby and the mother are re-tested, after two weeks, to determine who has PCD.[14] Treatment / Management The mainstay of primary carnitine deficiency involves lifelong treatment with a high dose of oral L-carnitine (100 to 200 mg/kg daily dose in 3 divided doses).[3][4] The oral bioavailability of L-carnitine is 5% to 18%.[5] L-carnitine is a fairly safe medication, and few side effects associated with high doses include diarrhea and intestinal discomfort
Analytical Quality Manufactured under rigorous quality control standards and tested using HPLC and LC-MS protocols to support purity evaluation, analytical confidence, formulation consistency, and reproducible laboratory research
Skin type matters Lighter skin types (Fitzpatrick I-II) usually see changes sooner and at lower doses
Ancans, J., Flanagan, N., Hoogduijn, M
2022;145(18):e895-1032